Present situation in the treatment of invasive fungal infection
International update symposium on fungal infections

Authors: de Pauw, B.E., Picazo, J.J.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 32(SUPP/2):S167-S171

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN070714186&indx=1&recIds=ETOCCN070714186

European expert opinion on the management of invasive candidiasis in adults

Authors: Kullberg, B.J., Verweij, P.E., Akova, M., Arendrup, M.C., Bille, J., Calandra, T., Cuenca-Estrella, M., Herbrecht, R., Jacobs, F., Kalin, M., Kibbler, C.C., Lortholary, O., Martino, P., Meis, J.F., Muñoz, P., Odds, F.C., De Pauw, B.E., Rex, J.H., Roilides, E., Rogers, T.R., Ruhnke, M., Ullmann, A.J., Uzun, Ö., Vandewoude, K., Vincent, J.-L., Donnelly, J.P.

Source: In Clinical Microbiology and Infection September 2011 17 Supplement 5:1-12

Editorial Commentary: Timely Intervention for Invasive Fungal Disease: Should the Road Now Lead to the Laboratory Instead of the Pharmacy?

Authors: de Pauw, B.E., Donnelly, J.P.

Source: CLINICAL INFECTIOUS DISEASES -CHICAGO-. 48(8):1052-1054

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN248538260&indx=1&recIds=ETOCRN248538260

Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity

Authors: Donnelly, J.P., De Pauw, B.E.

Source: In Clinical Microbiology and Infection 2004 10 Supplement 1:107-117

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis

Authors: Oude Lashof, A.M.L., De Bock, R., Herbrecht, R., de Pauw, B.E., Krcmery, V., Aoun, M., Akova, M., Cohen, J., Siffnerová, H., Egyed, M., Ellis, M., Marinus, A., Sylvester, R., Kullberg, B.J.

Source: In European Journal of Cancer 2004 40(9):1314-1319

Achievements and goals of the EORTC Invasive Fungal Infections Group

Authors: de Pauw, B.E, Herbrecht, R, Meunier, F

Source: In European Journal of Cancer 2002 38 Supplement 4:88-93

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy

Authors: Blijlevens, N.M.A., Donnelly, J.P., de Pauw, B.E.

Source: In Clinical Microbiology and Infection 2001 7 Supplement 4:47-52

Fungal infections: diagnostic problems and choice of therapy

Authors: de Pauw, B.E.

Source: LEUKEMIA SUPPLEMENTS. 1(2):S22-S23

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN353337875&indx=1&recIds=ETOCRN353337875

Individualization in the management of fungal disease in the transplant recipient.

Authors: de Pauw, B.E.¹, Rubin, R.H.

Source: Transplant Infectious Disease. Jun2007, Vol. 9 Issue 2, p87-88. 2p.

Subject Terms: *MYCOSES, *TRANSPLANTATION of organs, tissues, etc., *INFECTION, *THERAPEUTICS

Phase I Study of Recombinant Human Interferon Alpha-2C in Patients with Chemotherapy-Refractory Malignancies.

Authors: Janssen, J.Th.P., Ludwig, H., Scheithauer, W., de Pauw, B.E., Keyser, A., van Tol, R., Flener, R.

Source: Oncology; 1985 Supplement 1, Vol. 42 Issue S1, p3-6, 4p

The Challenge of Invasive Fungal Infection.

Authors: de Pauw, B.E., Meunier, F.

Source: Chemotherapy (0009-3157); 1999 Supplement 1, Vol. 45, p1-14, 14p

Treatment of Documented and Suspected Neutropenia-Associated Invasive Fungal Infections

Authors: De Pauw, B.E.

Source: Journal of Chemotherapy; January 2001, Vol. 13 Issue: Supplement 4 p181-192, 12p

Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient

Authors: DE PAUW, B.E., RAEMAEKERS, J.M.M., SCHATTENBERG, T., DONNELLY, J.P.

Source: Journal of Internal Medicine; July 1997, Vol. 242 Issue: Supplement 740 p69-77, 9p

Gram-positive bacteremia coincides with impaired gut integrity in HSCT recipients

Authors: Blijlevens, N.M.A., van t Land, B., Donnelly, J.P., de Pauw, B.E.

Source: In International Journal of Infectious Diseases 2002 6 Supplement 2:S32-S33

Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition.

Authors: Blijlevens, N.M.A., Donnelly, J.P., Meis, J.F.G.M., Verweij, P.E., de Pauw, B.E.

Source: Transplant Infectious Disease; Jun2002, Vol. 4 Issue 2, p64-65, 2p

Subject Terms: ASPERGILLUS, NEUTROPENIA, STEM cells, CELL transplantation

Caspofungin: A Viewpoint by Ben E. De Pauw.

Authors: de Pauw, B.E.¹

Source: Drugs. Jun2001, Vol. 61 Issue 8, p1130-1131. 2p.

Subject Terms: *ANTIFUNGAL agents, *MYCOSES, *COMMUNICABLE disease treatment, *AMPHOTERICIN B

Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia

Authors: Braken, J.B., Koopmans, P.P., Raemaekers, J.M.M., de Pauw, B.E.

Source: In European Journal of Cancer 1993 29(4):515-518

Early identification of neutropenic patients at risk of gram-positive bacteraemia and the impact of empirical administration of vancomycin

Authors: Dompeling, E.C., Donnelly, J.P., Deresinski, S.C., Feld, R., Lane-Allman, E.F., De Pauw, B.E.

Source: In European Journal of Cancer 1996 32(8):1332-1339

Management of relapse and survival in advanced stage Hodgkin's disease: The EORTC experience

Authors: Burgers, J.M.V. ^*, Somers, R., Henry-Amar, M., Tarayre, M., Carde, P., Thomas, J., Hagenbeek, A., Monconduit, M., de Pauw, B.E., Breed, W.P.M., Verdonck, L., Hayat, M., Zittoun, R.

Source: In Annals of Oncology February 1991 2 Supplement 2:63-66

Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease

Authors: De Mulder, P.H.M., Mier, P.D., De Pauw, B.E., Van Rennes, H., Janssen, J.Th.P., Wagener, D.J.T., Haanen, C.

Source: In European Journal of Cancer and Clinical Oncology 1983 19(3):333-337